Industry-Supported Symposia

The Role of Collagenase SANTYL Ointment in Wound Bed Preparation
Faculty: Michael Maier, DPM, CWS, FACWS

Abstract:

Most non-healing chronic wounds fail to progress through the normal phases of wound repair and instead remain chronically
inflamed. The inflammatory process creates a highly proteolytic and oxidative environment that results in the formation of cellular
debris and necrotic tissue. Fragments of necrotic tissue and cellular debris are powerful local stimuli, capable of sustaining a prolonged inflammatory process. Effective therapy in the
treatment of chronic wounds must disrupt the pro-inflammatory cycle and address the wound at both the macro- and micro-environment levels.

The Future of Tissue Regeneration: Scientific and Clinical Evidence Supporting the Use of Dehydrated Amniotic Membrane in Wound Healing
Faculty: William W. Li, MD; Rodney Stuck, DPM, FACFAS; Charles Zelen, DPM, FACFAS

Abstract

• Outline the differences in the processing of human amniotic membrane and how they affect the product composition, growth factor release and cytokines.

• Detail the mechanisms of action of dehydrated human amniotic tissue and applications for wound healing.

• Review new economic and randomized control trial data on PURION® processed amniotic tissue and its impact on DFU and VLU outcomes.

• Case study results on injectable applications of dehydrated human amniotic tissue for plantar fasciitis.

Supported by MiMedx

Biofilm and Wound Care: Understanding Biofilm’s Impact on Chronic Non-Healing Wounds
Faculty: Allen Gabriel, MD; Greg Schultz, PhD

Abstract: Chronic non-healing wounds affect a significant number of patients worldwide. Although the etiologies of these wounds are vastly different, bacterial infection has been suggested as a major factor responsible for the perpetual inflammation and tissue destruction. Dr. Greg Schultz of the University of Florida and Dr. Allen Gabriel of Southwest Medical Group Plastic Surgery will share the latest research, adjunctive wound care therapies, and case experiences that have been effective in treating such stagnant wounds.

Supported by KCI

Dermagraft® for the Treatment of Non-Healing Diabetic Foot Ulcers
Faculty: Damien Dauphinee, DPM, FACFAS, CWS-P

Abstract: In this Dermagraft presentation, attendees will have an opportunity to learn about the prevalence of obesity, diabetes, and diabetic foot ulcers (DFUs); review the clinical data for Dermagraft and who is an appropriate patient type for treatment with Dermagraft; and understand the proper preparation and application techniques of Dermagraft for the treatment of unhealed DFUs >6 weeks duration.

Supported by Shire Regenerative Medicine, Inc.

Friday, May 3, 2013 Breakfast: 7:30 a.m. – 9:00 a.m.

OASIS® Matrix Wound Management – A Sophisticated Structure for Challenging Wounds
Faculty:  David Zabel, MD, FACS

Abstract:Difficult to heal and chronic wounds are often the result of a dysfunctional extracellular matrix (ECM).  For normal wound healing to occur, the wound must have a variety of components, including a minimally damaged ECM and active ECM synthesis.  There are several approaches to correct a dysfunctional ECM, including the utilization of SIS (small intestinal submucosa) technology, which entails delivering a naturally derived, structurally intact ECM material to the wound to promote epithelialization of the chronic wound.

Supported by Healthpoint Biotherapeutics

Demystifying Debridement Modalities: An Interdisciplinary Panel Perspective
Faculty: Ira M. Herman, PhD; Michael Maier, DPM, CWS, FACCWS; Catherine T. Milne, APRN, MSN, CWOCN, CS, ANP; Pamela Scarborough, PT, DPT, MS, CDE, CWS

Learning Objectives

• Define autolytic debridement as the body’s natural ability to heal itself
• Compare and contrast various debridement modalities mechanism of action
• Describe the science of enzymatic debridement
• Review challenging cases of difficult-to-heal wounds where enzymatic debridement agents were used

Supported by an educational grant from Healthpoint Biotherapeutics.

Patient-Centered Approaches to Managing Diabetic Foot Ulcers
Faculty: Robert S. Kirsner, MD, PhD; David Margolis, MD, PhD; William Marston, MD

Learning Objectives

• Discuss the importance of complications of diabetes mellitus and medical impact on diabetic foot ulceration
• Identify patients at high risk for poor diabetic foot ulcer healing
• Develop approaches to improving outcomes in patients with diabetic foot ulcers

Supported by an educational grant from Shire Regenerative Medicine, Inc.

An Interactive Case-Based Model to Managing Diabetic Foot Ulcers: The Role of Platelet-Derived Growth Factor
Faculty: William W. Li, MD; Vickie R. Driver, MS, DPM, FACFAS; Donald Miller, ScD; Gregory Schultz, PhD

Learning Objectives

• Describe the role of platelet-derived growth factor (PDGF) in stimulating the wound healing process
• Summarize the latest safety data on adjunctive therapy based on PDGF to diabetic foot ulcer healing
• Define and employ basic tenets of proper diabetic foot wound care to optimize the effectiveness of PDGF-based adjunctive therapy
• Review case-based scenarios and discuss clinical pearls acquired from the use of PDGF-based adjunctive therapy in diabetic foot ulcer care.

Supported by an educational grant from Healthpoint Biotherapeutics.

Clinical and Financial Impacts of Hydrophobic Bacteria-Binding Therapy in Chronic Wounds
Faculty: Jim McGuire, DPM, PT, CPed, FAPWCA; Dot Weir, RN, CWON, CWS

Learning Objectives

• Explore prophylactic use of hydrophobic bacteria-binding dressings to prevent wound infections
• Discuss the clinical impact of using hydrophobic bacteria-binding dressings at the onset of chronic wounds to reduce bioburden and promote the natural cascade of healing events
• Measure the financial impact of using antimicrobials versus bacterial binding therapy
• Discuss emerging changes in payment schema and how that might impact decisions to use advanced wound products

Supported by an educational grant from BSN Medical.

A Multi-Faceted Expert’s Approach to Managing Venous Disease and Venous Leg Ulcers
Faculty: William Marston, MD

Learning Objectives

• Describe the incidence, financial and clinical burden, and associated comorbidities of venous disease
• Explore evidence-based approaches and best practices in managing venous disease and venous leg ulcers
• Review challenging cases of venous leg ulcers and practical approaches to management

Supported by an educational grant from Organogenesis, Inc.

Clinical Implications of Unmodulated pH within the Wound Environment and the Effects of Active Leptospermum Honey on Surface pH of Chronic Wounds
Faculty: Marco Romanelli, MD, PhD; Karen Zulkowski, DNS, RN

Learning Objectives

• Evaluate the role of pH on cellular events in the wound healing process
• Compare healing of wounds in an acidic environment versus an elevated alkaline environment
• Explore the effects of lowered wound pH in aiding wound healing by reducing protease activity and increasing fibroblast activity and oxygen release
• Review studies associating the use ALH in altering surface pH in wounds and reducing wound size

Supported by an educational grant from Derma Sciences, Inc.

Sponsored by North American Center for Continuing Medical Education, LLC

Activities Overview
To be eligible for credit, participants must attend the full activities and complete the evaluations following the educational sessions. Participants who complete the evaluations online at www.naccme.com will immediately receive documentation of credit. Participants who submit a hard copy evaluation will receive documentation of credit within 8 weeks.

Intended Learners

Identifying Patients at High Risk for Poor Diabetic Foot Ulcer Healing and Lower-Extremity Amputations: Approaches to Improving Outcomes

A Multi-Faceted Expert’s Approach to Managing Venous Disease and Venous Leg Ulcers

Clinical and Financial Impacts of Hydrophobic Bacteria-Binding Therapy in Chronic Wounds

Patient-Centered Approaches to Managing Non-Healing, Chronic Wounds: Novel Uses of Mechanically Powered NPWT System

Today's Science is Tomorrow’s New Treatment Option: Emerging Cell-Based Therapy for Difficult-to-Heal Wounds

Clinical Implications of Unmodulated pH within the Wound Environment and the Effects of Active Leptospermum Honey on Surface pH of Chronic Wounds

These activities are designed for physicians, podiatrists, physical therapists and nurses involved in wound healing or wound care issues.

Demystifying Debridement Modalities: An Interdisciplinary Panel Perspective

An Interactive Case-Based Model to Managing Diabetic Foot Ulcers: The Role of Platelet-Derived Growth Factor

These activities are designed for physicians, podiatrists, physical therapists, pharmacists and nurses involved in wound healing or wound care issues.

There is no fee associated with these activities.

Hardware/Software Requirements
The evaluations are accessible after the activities via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME
NACCME designates each of these live activities for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in each activity.

CNE
These continuing nursing education activities awards 1.0 contact hour each.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour each

CPME
North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.

These programs are approved for 1.0 continuing education contact hour or 0.1 CEU each.

The Interactive Case-Based Model to Managing Diabetic Foot Ulcers Symposium (UAN 0276-0000-13-020-L01-P) and Demystifying Debridement Modalities Symposium (UAN 0276-0000-13-019-L01-P) are also accredited for pharmacists and physical therapists.

CPE
These activities are approved for 1 contact hour (0.1 CEU) each of continuing pharmacy education.

These educational activities are knowledge-based activities.

The Patient-Centered Approaches to Managing Non-Healing, Chronic Wounds: Novel Uses of Mechanically Powered NPWT System and Today's Science is Tomorrow’s New Treatment Option: Emerging Cell-Based Therapy for Difficult-to-Heal Wounds will also be accredited for Physical Therapists

Physical Therapists: North American Center for Continuing Medical Education, LLC (NACCME), has applied for pre-approval accreditation in California, Florida, Louisiana, Ohio, and Texas which require preapproval. If you practice in another state, please consult its PT board.

ADA Statement
North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

For questions regarding these educational activities, please call 609-371-1137.

REGISTRATION: Please have your confirmation code ready. You will be prompted to enter this confirmation code to register for these symposia.